Food Safety Modernization Act Domestic and Foreign Facility Reinspections, Recall, and Importer Reinspection User Fee Rates for Fiscal Year 2012; Extension of Comment Period, 66723 [2011-27845]

Download as PDF Federal Register / Vol. 76, No. 208 / Thursday, October 27, 2011 / Notices FOR FURTHER INFORMATION CONTACT: Karen Shields, Grants Policy Specialist, Department of Health and Human Services, Administration for Children and Families, OA/Division of Grants Policy, 370 L’Enfant Promenade, SW., Aerospace Building, 6th Floor East, Washington, DC 20447. Email: karen.shields@acf.hhs.gov. Fax: (202) 205–6400. Dated: October 21, 2011. Jason Donaldson, Deputy Assistant Secretary for Administration, Administration for Children and Families. [FR Doc. 2011–27878 Filed 10–26–11; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0528] Food Safety Modernization Act Domestic and Foreign Facility Reinspections, Recall, and Importer Reinspection User Fee Rates for Fiscal Year 2012; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. The Food and Drug Administration (FDA) is extending the comment period to November 30, 2011, for the notice entitled, ‘‘Food Safety Modernization Act Domestic and Foreign Facility Reinspections, Recall, and Importer Reinspection User Fee Rates for Fiscal Year 2012’’ that appeared in the Federal Register of August 1, 2011 (76 FR 45820). In that document, FDA announced the establishment of a docket to obtain comments that would be considered in establishing the fee rates for fiscal year (FY) 2013. In particular, the Agency provided the current FY 2012 fees and requested public comments to the document and intends to consider such comments, as well as experience and additional data gained in implementing these fees in FY 2012, in establishing the fee rates for FY 2013. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. DATES: Submit either electronic or written comments by November 30, 2011. ADDRESSES: Submit electronic comments to https:// wreier-aviles on DSK7SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 14:47 Oct 26, 2011 Jkt 226001 www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. 66723 Dated: October 24, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011–27845 Filed 10–26–11; 8:45 am] BILLING CODE 4160–01–P FOR FURTHER INFORMATION CONTACT: Amy Waltrip, 12420 Parklawn Dr., rm. 2012, Rockville, MD 20857, (301) 796– 8811, email: Amy.Waltrip@fda.hhs.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES SUPPLEMENTARY INFORMATION: National Institutes of Health I. Background Submission for OMB Review; Comment Request: National Institutes of Health Construction Grants In the Federal Register of August 1, 2011 (76 FR 45820), FDA published a notice with a 90-day comment period to request comments on the establishment of domestic and foreign facility reinspections, non-compliance with recall order, and importer reinspection FY 2012 user fees. The FDA Food Safety Modernization Act provides the Agency with authority under section 743 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–31) to assess and collect fees, including those for costs associated with certain domestic and foreign facility reinspections, failure to comply with a recall order, and importer reinspections. The Agency is seeking public comment on the established FY 2012 user fees. In particular, the Agency is seeking public comments intending to consider such comments, as well as experience and additional data gained in implementing these user fees in FY 2012, in establishing the fee rates for FY 2013. The Agency has received a request for an extension of the comment period. The request conveyed concern that the current 90-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the notice. FDA has considered the request and is extending the comment period for the notice for 30 days until November 30, 2011. The Agency believes that this extension allows adequate time for interested persons to submit comments. II. Request for Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments on this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on August 17, 2011, pages 51042–51043, and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The NIH may not conduct or sponsor, and the respondent is not required to respond to, information that has been extended, revised or implemented on or after October 1, 2008, unless it displays a currently valid OMB control number. Proposed Collection: Title: National Institutes of Health Construction GrantsB42 CFR part 52b (Final Rule). Type of Information Collection Request: Extension of No. 0925–0424, expiration date 8/31/2008. Need and Use of the Information Collection: This request is for OMB review and approval of an extension for the information collection and recordkeeping requirements contained in the regulation codified at 42 CFR part 52b. The purpose of the regulation is to govern the awarding and administration of grants awarded by NIH and its components for construction of new buildings and the alteration, renovation, remodeling, improvement, expansion, and repair of existing buildings, including the provision of equipment necessary to make the buildings (or applicable part of the buildings) suitable for the purpose for which it was constructed. In terms of reporting requirements: Section 52b.9(b) of the regulation requires the transferor of a facility which is sold or transferred, or owner of a facility, the use of which has changed, to provide written notice of the sale, transfer or change within 30 days. Section 52b.10(f) requires a grantee to submit an approved copy of the construction E:\FR\FM\27OCN1.SGM 27OCN1

Agencies

[Federal Register Volume 76, Number 208 (Thursday, October 27, 2011)]
[Notices]
[Page 66723]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27845]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0528]


Food Safety Modernization Act Domestic and Foreign Facility 
Reinspections, Recall, and Importer Reinspection User Fee Rates for 
Fiscal Year 2012; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending the 
comment period to November 30, 2011, for the notice entitled, ``Food 
Safety Modernization Act Domestic and Foreign Facility Reinspections, 
Recall, and Importer Reinspection User Fee Rates for Fiscal Year 2012'' 
that appeared in the Federal Register of August 1, 2011 (76 FR 45820). 
In that document, FDA announced the establishment of a docket to obtain 
comments that would be considered in establishing the fee rates for 
fiscal year (FY) 2013. In particular, the Agency provided the current 
FY 2012 fees and requested public comments to the document and intends 
to consider such comments, as well as experience and additional data 
gained in implementing these fees in FY 2012, in establishing the fee 
rates for FY 2013. The Agency is taking this action in response to 
requests for an extension to allow interested persons additional time 
to submit comments.

DATES: Submit either electronic or written comments by November 30, 
2011.

ADDRESSES: Submit electronic comments to https://www.regulations.gov. 
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Amy Waltrip, 12420 Parklawn Dr., rm. 
2012, Rockville, MD 20857, (301) 796-8811, email: 
Amy.Waltrip@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of August 1, 2011 (76 FR 45820), FDA 
published a notice with a 90-day comment period to request comments on 
the establishment of domestic and foreign facility reinspections, non-
compliance with recall order, and importer reinspection FY 2012 user 
fees. The FDA Food Safety Modernization Act provides the Agency with 
authority under section 743 of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 379j-31) to assess and collect fees, including those for 
costs associated with certain domestic and foreign facility 
reinspections, failure to comply with a recall order, and importer 
reinspections. The Agency is seeking public comment on the established 
FY 2012 user fees. In particular, the Agency is seeking public comments 
intending to consider such comments, as well as experience and 
additional data gained in implementing these user fees in FY 2012, in 
establishing the fee rates for FY 2013. The Agency has received a 
request for an extension of the comment period. The request conveyed 
concern that the current 90-day comment period does not allow 
sufficient time to develop a meaningful or thoughtful response to the 
notice.
    FDA has considered the request and is extending the comment period 
for the notice for 30 days until November 30, 2011. The Agency believes 
that this extension allows adequate time for interested persons to 
submit comments.

II. Request for Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments on this document. 
It is only necessary to send one set of comments. It is no longer 
necessary to send two copies of mailed comments. Identify comments with 
the docket number found in brackets in the heading of this document. 
Received comments may be seen in the Division of Dockets Management 
between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: October 24, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-27845 Filed 10-26-11; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.